Announcements

Job Offers

"Tweeting Growers"

Top 5 -yesterday

Top 5 -last week

Top 5 -last month

Marapharm Ventures purchases 1.5 million units of Veritas Pharma

Marapharm has filed an early warning report advising that it has purchased a total of 1,500,000 units of Veritas Pharma at a purchase price of $0.28 per unit, each unit consisting of one common share in the share capital of the Issuer and one common share purchase warrant of the issuer, exercisable at a price of $0.45 per common share for a period of 18 months.

At the close of the issuer’s unit offering, Marapharm’s ownership of the 1,500,000 common shares, represents approximately 3.48% of the issuer’s 43,136,923 issued and outstanding common shares, and assuming the exercise of the 1,500,000 warrants, would represent 6.72% of the issued and outstanding common shares of the Issuer.

Immediately before the transaction, Marapharm owned and controlled a total of 5,000,000 common shares representing approximately 11.59% in the current share capital of the issuer, and 5,000,000 warrant shares in the share capital of the issuer (the warrants purchased as a unit with the 5,000,000 common shares), and an additional 5,000,000 warrants of the Issuer to purchase one common share in the share capital of the issuer on the exercise of the 5,000,000 additional warrants.

Marapharm now holds a total of 6,500,000 common shares, representing approximately 15.1% in the share capital of the issuer, and assuming the exercise of the company’s total 11,500,000 warrants, Marapharm would hold a total of 18,000,000 common shares or approximately 32.94% of the issued and outstanding common shares of the issuer.

The securities were acquired for investment purposes and, subject to regulatory requirements, the company may acquire additional securities of the issuer in the future.

The common shares of the issuer are listed on the Canadian Securities Exchange and were acquired or subscribed for pursuant to an offering of units conducted by the issuer.

For more information:
Marapharm
778-583-4476
info@marapharm.com
www.marapharm.com

Publication date:



Receive the daily newsletter in your email for free | Click here


Other news in this sector:


Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber